[
  {
    "text": "(\"MMT'). SIGA and MMT are sometimes referred to individually as a \"Party' and collectively as the \"Parties\"..",
    "bbox": [
      112,
      149,
      943,
      162
    ],
    "label": 2,
    "category": "Parties"
  },
  {
    "text": "RECITALS",
    "bbox": [
      624,
      166,
      711,
      176
    ],
    "label": 2,
    "category": "Parties"
  },
  {
    "text": "This Promotion AgreemEnt (this \"Agreement) is entered into as of May 31, 2019 (the \"Effective Date\") by and between SIGA",
    "bbox": [
      179,
      102,
      1000,
      113
    ],
    "label": 3,
    "category": "Agreement Date"
  },
  {
    "text": "This Promotion AgreemEnt (this \"Agreement) is entered into as of May 31, 2019 (the \"Effective Date\") by and between SIGA",
    "bbox": [
      179,
      102,
      1000,
      113
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "PROMOTION AGREEMENT",
    "bbox": [
      555,
      86,
      777,
      96
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "This Promotion AgreemEnt (this \"Agreement) is entered into as of May 31, 2019 (the \"Effective Date\") by and between SIGA",
    "bbox": [
      179,
      102,
      1000,
      113
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "TEchnoLogIEs, Inc., a Delaware corporation having an address at 31 East 62nd Street, New York, NY 10065 (\"SIGA'), and MeRIDiAn MeDIcAL",
    "bbox": [
      112,
      118,
      1000,
      130
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "TechnoLogies, Inc., a Pfizer company, and Delaware corporation having an address at 6350 Stevens Forest Road, Suite #301, Columbia, MD 21046",
    "bbox": [
      111,
      134,
      1000,
      146
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "(\"MMT'). SIGA and MMT are sometimes referred to individually as a \"Party' and collectively as the \"Parties\"..",
    "bbox": [
      112,
      149,
      943,
      162
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "RECITALS",
    "bbox": [
      624,
      166,
      711,
      176
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "WHeREAs, SIGA developed the FDA-approved oral capsule formulation of TPOXX (tecovirimat) for the treatment of smallpox;.",
    "bbox": [
      180,
      182,
      1000,
      194
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "WhereAs, MMT possesses resources and expertise in the marketing, promoting, advertising, offering for sale and selling of",
    "bbox": [
      180,
      198,
      1000,
      210
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "pharmaceutical and antiviral products; and",
    "bbox": [
      113,
      215,
      432,
      225
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "WheReAs, MMT desires to obtain from SIGA, and SIGA desires to grant to MMT certain exclusive licenses in the Territory to market.",
    "bbox": [
      179,
      230,
      1000,
      241
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "promote, advertise, offer for sale and sell the Product in the Field in the Territory, as set forth herein.",
    "bbox": [
      111,
      245,
      860,
      258
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "Now, ThereFore, in consideration of the foregoing premises and the mutual promises, covenants and conditions contained in this",
    "bbox": [
      178,
      262,
      1000,
      274
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "Agreement, the Parties hereby agree as follows:",
    "bbox": [
      113,
      278,
      470,
      290
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "ARTICLE 1",
    "bbox": [
      624,
      294,
      708,
      304
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "DEFINITIONS",
    "bbox": [
      613,
      326,
      720,
      336
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "\"Active Country\" has the meaning set forth in Section 4.4(b)",
    "bbox": [
      179,
      342,
      637,
      354
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "\"Affiliate\"' means, with respect to each Party, any corporation, firm, partnership or other entity or Person which directly or indirectly.",
    "bbox": [
      180,
      358,
      1000,
      370
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "controls or is controlled by or is under common control with that Party. A Person will be regarded as in \"control' (including, with correlative",
    "bbox": [
      111,
      374,
      1000,
      386
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "meaning, the terms \"controlled by\" and \"under common control with') of another Person if it (a) owns or controls at least fifty percent (50%) of the",
    "bbox": [
      111,
      390,
      1000,
      402
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "equity securities of the subject Person entitled to vote in the election of directors, or (b) possesses, directly or indirectly, the power to direct or",
    "bbox": [
      113,
      406,
      1000,
      418
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "cause the direction of the management or policies of any such Person (whether through ownership of securities or other ownership interests, by",
    "bbox": [
      111,
      421,
      1000,
      434
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "contract or otherwise).",
    "bbox": [
      112,
      438,
      281,
      449
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "\"Alliance Manager' has the meaning set forth in Section 3.1(d).",
    "bbox": [
      179,
      453,
      654,
      465
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "\"Anti-Corruption Law\" means any applicable Law of any jurisdiction concerning or relating to bribery, kickbacks or corruption including.",
    "bbox": [
      179,
      469,
      1000,
      482
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "the United States Foreign Corrupt Practices Act of 1977, the Anti-Kickback Statute, the UK Bribery Act 2010, any Laws enacted pursuant to the",
    "bbox": [
      112,
      486,
      1000,
      498
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "OECD Convention on Combating Bribery of Foreign Public Officials, and other similar anti-corruption legislation in other jurisdictions, as may be",
    "bbox": [
      111,
      501,
      1000,
      514
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "amended from time to time and each to the extent applicable to a Party.",
    "bbox": [
      111,
      516,
      637,
      531
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "Source: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019",
    "bbox": [
      133,
      1000,
      528,
      1000
    ],
    "label": 15,
    "category": "Termination For Convenience"
  },
  {
    "text": "PROMOTION AGREEMENT",
    "bbox": [
      555,
      86,
      777,
      96
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "This Promotion AgreemEnt (this \"Agreement) is entered into as of May 31, 2019 (the \"Effective Date\") by and between SIGA",
    "bbox": [
      179,
      102,
      1000,
      113
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "TEchnoLogIEs, Inc., a Delaware corporation having an address at 31 East 62nd Street, New York, NY 10065 (\"SIGA'), and MeRIDiAn MeDIcAL",
    "bbox": [
      112,
      118,
      1000,
      130
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "TechnoLogies, Inc., a Pfizer company, and Delaware corporation having an address at 6350 Stevens Forest Road, Suite #301, Columbia, MD 21046",
    "bbox": [
      111,
      134,
      1000,
      146
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "(\"MMT'). SIGA and MMT are sometimes referred to individually as a \"Party' and collectively as the \"Parties\"..",
    "bbox": [
      112,
      149,
      943,
      162
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "RECITALS",
    "bbox": [
      624,
      166,
      711,
      176
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "WHeREAs, SIGA developed the FDA-approved oral capsule formulation of TPOXX (tecovirimat) for the treatment of smallpox;.",
    "bbox": [
      180,
      182,
      1000,
      194
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "WhereAs, MMT possesses resources and expertise in the marketing, promoting, advertising, offering for sale and selling of",
    "bbox": [
      180,
      198,
      1000,
      210
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "pharmaceutical and antiviral products; and",
    "bbox": [
      113,
      215,
      432,
      225
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "WheReAs, MMT desires to obtain from SIGA, and SIGA desires to grant to MMT certain exclusive licenses in the Territory to market.",
    "bbox": [
      179,
      230,
      1000,
      241
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "promote, advertise, offer for sale and sell the Product in the Field in the Territory, as set forth herein.",
    "bbox": [
      111,
      245,
      860,
      258
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Now, ThereFore, in consideration of the foregoing premises and the mutual promises, covenants and conditions contained in this",
    "bbox": [
      178,
      262,
      1000,
      274
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Agreement, the Parties hereby agree as follows:",
    "bbox": [
      113,
      278,
      470,
      290
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "ARTICLE 1",
    "bbox": [
      624,
      294,
      708,
      304
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "DEFINITIONS",
    "bbox": [
      613,
      326,
      720,
      336
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "\"Active Country\" has the meaning set forth in Section 4.4(b)",
    "bbox": [
      179,
      342,
      637,
      354
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "\"Affiliate\"' means, with respect to each Party, any corporation, firm, partnership or other entity or Person which directly or indirectly.",
    "bbox": [
      180,
      358,
      1000,
      370
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "controls or is controlled by or is under common control with that Party. A Person will be regarded as in \"control' (including, with correlative",
    "bbox": [
      111,
      374,
      1000,
      386
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "meaning, the terms \"controlled by\" and \"under common control with') of another Person if it (a) owns or controls at least fifty percent (50%) of the",
    "bbox": [
      111,
      390,
      1000,
      402
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "equity securities of the subject Person entitled to vote in the election of directors, or (b) possesses, directly or indirectly, the power to direct or",
    "bbox": [
      113,
      406,
      1000,
      418
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "cause the direction of the management or policies of any such Person (whether through ownership of securities or other ownership interests, by",
    "bbox": [
      111,
      421,
      1000,
      434
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "contract or otherwise).",
    "bbox": [
      112,
      438,
      281,
      449
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "\"Alliance Manager' has the meaning set forth in Section 3.1(d).",
    "bbox": [
      179,
      453,
      654,
      465
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "\"Anti-Corruption Law\" means any applicable Law of any jurisdiction concerning or relating to bribery, kickbacks or corruption including.",
    "bbox": [
      179,
      469,
      1000,
      482
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "the United States Foreign Corrupt Practices Act of 1977, the Anti-Kickback Statute, the UK Bribery Act 2010, any Laws enacted pursuant to the",
    "bbox": [
      112,
      486,
      1000,
      498
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "OECD Convention on Combating Bribery of Foreign Public Officials, and other similar anti-corruption legislation in other jurisdictions, as may be",
    "bbox": [
      111,
      501,
      1000,
      514
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "amended from time to time and each to the extent applicable to a Party.",
    "bbox": [
      111,
      516,
      637,
      531
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Source: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019",
    "bbox": [
      133,
      1000,
      528,
      1000
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "PROMOTION AGREEMENT",
    "bbox": [
      555,
      86,
      777,
      96
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "This Promotion AgreemEnt (this \"Agreement) is entered into as of May 31, 2019 (the \"Effective Date\") by and between SIGA",
    "bbox": [
      179,
      102,
      1000,
      113
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "TEchnoLogIEs, Inc., a Delaware corporation having an address at 31 East 62nd Street, New York, NY 10065 (\"SIGA'), and MeRIDiAn MeDIcAL",
    "bbox": [
      112,
      118,
      1000,
      130
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "TechnoLogies, Inc., a Pfizer company, and Delaware corporation having an address at 6350 Stevens Forest Road, Suite #301, Columbia, MD 21046",
    "bbox": [
      111,
      134,
      1000,
      146
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "(\"MMT'). SIGA and MMT are sometimes referred to individually as a \"Party' and collectively as the \"Parties\"..",
    "bbox": [
      112,
      149,
      943,
      162
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "RECITALS",
    "bbox": [
      624,
      166,
      711,
      176
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "WHeREAs, SIGA developed the FDA-approved oral capsule formulation of TPOXX (tecovirimat) for the treatment of smallpox;.",
    "bbox": [
      180,
      182,
      1000,
      194
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "WhereAs, MMT possesses resources and expertise in the marketing, promoting, advertising, offering for sale and selling of",
    "bbox": [
      180,
      198,
      1000,
      210
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "pharmaceutical and antiviral products; and",
    "bbox": [
      113,
      215,
      432,
      225
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "WheReAs, MMT desires to obtain from SIGA, and SIGA desires to grant to MMT certain exclusive licenses in the Territory to market.",
    "bbox": [
      179,
      230,
      1000,
      241
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "promote, advertise, offer for sale and sell the Product in the Field in the Territory, as set forth herein.",
    "bbox": [
      111,
      245,
      860,
      258
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "Now, ThereFore, in consideration of the foregoing premises and the mutual promises, covenants and conditions contained in this",
    "bbox": [
      178,
      262,
      1000,
      274
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "Agreement, the Parties hereby agree as follows:",
    "bbox": [
      113,
      278,
      470,
      290
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "ARTICLE 1",
    "bbox": [
      624,
      294,
      708,
      304
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "DEFINITIONS",
    "bbox": [
      613,
      326,
      720,
      336
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "\"Active Country\" has the meaning set forth in Section 4.4(b)",
    "bbox": [
      179,
      342,
      637,
      354
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "\"Affiliate\"' means, with respect to each Party, any corporation, firm, partnership or other entity or Person which directly or indirectly.",
    "bbox": [
      180,
      358,
      1000,
      370
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "controls or is controlled by or is under common control with that Party. A Person will be regarded as in \"control' (including, with correlative",
    "bbox": [
      111,
      374,
      1000,
      386
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "meaning, the terms \"controlled by\" and \"under common control with') of another Person if it (a) owns or controls at least fifty percent (50%) of the",
    "bbox": [
      111,
      390,
      1000,
      402
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "equity securities of the subject Person entitled to vote in the election of directors, or (b) possesses, directly or indirectly, the power to direct or",
    "bbox": [
      113,
      406,
      1000,
      418
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "cause the direction of the management or policies of any such Person (whether through ownership of securities or other ownership interests, by",
    "bbox": [
      111,
      421,
      1000,
      434
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "contract or otherwise).",
    "bbox": [
      112,
      438,
      281,
      449
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "\"Alliance Manager' has the meaning set forth in Section 3.1(d).",
    "bbox": [
      179,
      453,
      654,
      465
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "\"Anti-Corruption Law\" means any applicable Law of any jurisdiction concerning or relating to bribery, kickbacks or corruption including.",
    "bbox": [
      179,
      469,
      1000,
      482
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "the United States Foreign Corrupt Practices Act of 1977, the Anti-Kickback Statute, the UK Bribery Act 2010, any Laws enacted pursuant to the",
    "bbox": [
      112,
      486,
      1000,
      498
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "OECD Convention on Combating Bribery of Foreign Public Officials, and other similar anti-corruption legislation in other jurisdictions, as may be",
    "bbox": [
      111,
      501,
      1000,
      514
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "amended from time to time and each to the extent applicable to a Party.",
    "bbox": [
      111,
      516,
      637,
      531
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "Source: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019",
    "bbox": [
      133,
      1000,
      528,
      1000
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "PROMOTION AGREEMENT",
    "bbox": [
      555,
      86,
      777,
      96
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "This Promotion AgreemEnt (this \"Agreement) is entered into as of May 31, 2019 (the \"Effective Date\") by and between SIGA",
    "bbox": [
      179,
      102,
      1000,
      113
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "TEchnoLogIEs, Inc., a Delaware corporation having an address at 31 East 62nd Street, New York, NY 10065 (\"SIGA'), and MeRIDiAn MeDIcAL",
    "bbox": [
      112,
      118,
      1000,
      130
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "TechnoLogies, Inc., a Pfizer company, and Delaware corporation having an address at 6350 Stevens Forest Road, Suite #301, Columbia, MD 21046",
    "bbox": [
      111,
      134,
      1000,
      146
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "(\"MMT'). SIGA and MMT are sometimes referred to individually as a \"Party' and collectively as the \"Parties\"..",
    "bbox": [
      112,
      149,
      943,
      162
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "RECITALS",
    "bbox": [
      624,
      166,
      711,
      176
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "WHeREAs, SIGA developed the FDA-approved oral capsule formulation of TPOXX (tecovirimat) for the treatment of smallpox;.",
    "bbox": [
      180,
      182,
      1000,
      194
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "WhereAs, MMT possesses resources and expertise in the marketing, promoting, advertising, offering for sale and selling of",
    "bbox": [
      180,
      198,
      1000,
      210
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "pharmaceutical and antiviral products; and",
    "bbox": [
      113,
      215,
      432,
      225
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "WheReAs, MMT desires to obtain from SIGA, and SIGA desires to grant to MMT certain exclusive licenses in the Territory to market.",
    "bbox": [
      179,
      230,
      1000,
      241
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "promote, advertise, offer for sale and sell the Product in the Field in the Territory, as set forth herein.",
    "bbox": [
      111,
      245,
      860,
      258
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Now, ThereFore, in consideration of the foregoing premises and the mutual promises, covenants and conditions contained in this",
    "bbox": [
      178,
      262,
      1000,
      274
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Agreement, the Parties hereby agree as follows:",
    "bbox": [
      113,
      278,
      470,
      290
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "ARTICLE 1",
    "bbox": [
      624,
      294,
      708,
      304
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "DEFINITIONS",
    "bbox": [
      613,
      326,
      720,
      336
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "\"Active Country\" has the meaning set forth in Section 4.4(b)",
    "bbox": [
      179,
      342,
      637,
      354
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "\"Affiliate\"' means, with respect to each Party, any corporation, firm, partnership or other entity or Person which directly or indirectly.",
    "bbox": [
      180,
      358,
      1000,
      370
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "controls or is controlled by or is under common control with that Party. A Person will be regarded as in \"control' (including, with correlative",
    "bbox": [
      111,
      374,
      1000,
      386
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "meaning, the terms \"controlled by\" and \"under common control with') of another Person if it (a) owns or controls at least fifty percent (50%) of the",
    "bbox": [
      111,
      390,
      1000,
      402
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "equity securities of the subject Person entitled to vote in the election of directors, or (b) possesses, directly or indirectly, the power to direct or",
    "bbox": [
      113,
      406,
      1000,
      418
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "cause the direction of the management or policies of any such Person (whether through ownership of securities or other ownership interests, by",
    "bbox": [
      111,
      421,
      1000,
      434
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "contract or otherwise).",
    "bbox": [
      112,
      438,
      281,
      449
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "\"Alliance Manager' has the meaning set forth in Section 3.1(d).",
    "bbox": [
      179,
      453,
      654,
      465
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "\"Anti-Corruption Law\" means any applicable Law of any jurisdiction concerning or relating to bribery, kickbacks or corruption including.",
    "bbox": [
      179,
      469,
      1000,
      482
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "the United States Foreign Corrupt Practices Act of 1977, the Anti-Kickback Statute, the UK Bribery Act 2010, any Laws enacted pursuant to the",
    "bbox": [
      112,
      486,
      1000,
      498
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "OECD Convention on Combating Bribery of Foreign Public Officials, and other similar anti-corruption legislation in other jurisdictions, as may be",
    "bbox": [
      111,
      501,
      1000,
      514
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "amended from time to time and each to the extent applicable to a Party.",
    "bbox": [
      111,
      516,
      637,
      531
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Source: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019",
    "bbox": [
      133,
      1000,
      528,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "PROMOTION AGREEMENT",
    "bbox": [
      555,
      86,
      777,
      96
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "This Promotion AgreemEnt (this \"Agreement) is entered into as of May 31, 2019 (the \"Effective Date\") by and between SIGA",
    "bbox": [
      179,
      102,
      1000,
      113
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "TEchnoLogIEs, Inc., a Delaware corporation having an address at 31 East 62nd Street, New York, NY 10065 (\"SIGA'), and MeRIDiAn MeDIcAL",
    "bbox": [
      112,
      118,
      1000,
      130
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "TechnoLogies, Inc., a Pfizer company, and Delaware corporation having an address at 6350 Stevens Forest Road, Suite #301, Columbia, MD 21046",
    "bbox": [
      111,
      134,
      1000,
      146
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "(\"MMT'). SIGA and MMT are sometimes referred to individually as a \"Party' and collectively as the \"Parties\"..",
    "bbox": [
      112,
      149,
      943,
      162
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "RECITALS",
    "bbox": [
      624,
      166,
      711,
      176
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "WHeREAs, SIGA developed the FDA-approved oral capsule formulation of TPOXX (tecovirimat) for the treatment of smallpox;.",
    "bbox": [
      180,
      182,
      1000,
      194
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "WhereAs, MMT possesses resources and expertise in the marketing, promoting, advertising, offering for sale and selling of",
    "bbox": [
      180,
      198,
      1000,
      210
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "pharmaceutical and antiviral products; and",
    "bbox": [
      113,
      215,
      432,
      225
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "WheReAs, MMT desires to obtain from SIGA, and SIGA desires to grant to MMT certain exclusive licenses in the Territory to market.",
    "bbox": [
      179,
      230,
      1000,
      241
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "promote, advertise, offer for sale and sell the Product in the Field in the Territory, as set forth herein.",
    "bbox": [
      111,
      245,
      860,
      258
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "Now, ThereFore, in consideration of the foregoing premises and the mutual promises, covenants and conditions contained in this",
    "bbox": [
      178,
      262,
      1000,
      274
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "Agreement, the Parties hereby agree as follows:",
    "bbox": [
      113,
      278,
      470,
      290
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "ARTICLE 1",
    "bbox": [
      624,
      294,
      708,
      304
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "DEFINITIONS",
    "bbox": [
      613,
      326,
      720,
      336
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "\"Active Country\" has the meaning set forth in Section 4.4(b)",
    "bbox": [
      179,
      342,
      637,
      354
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "\"Affiliate\"' means, with respect to each Party, any corporation, firm, partnership or other entity or Person which directly or indirectly.",
    "bbox": [
      180,
      358,
      1000,
      370
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "controls or is controlled by or is under common control with that Party. A Person will be regarded as in \"control' (including, with correlative",
    "bbox": [
      111,
      374,
      1000,
      386
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "meaning, the terms \"controlled by\" and \"under common control with') of another Person if it (a) owns or controls at least fifty percent (50%) of the",
    "bbox": [
      111,
      390,
      1000,
      402
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "equity securities of the subject Person entitled to vote in the election of directors, or (b) possesses, directly or indirectly, the power to direct or",
    "bbox": [
      113,
      406,
      1000,
      418
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "cause the direction of the management or policies of any such Person (whether through ownership of securities or other ownership interests, by",
    "bbox": [
      111,
      421,
      1000,
      434
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "contract or otherwise).",
    "bbox": [
      112,
      438,
      281,
      449
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "\"Alliance Manager' has the meaning set forth in Section 3.1(d).",
    "bbox": [
      179,
      453,
      654,
      465
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "\"Anti-Corruption Law\" means any applicable Law of any jurisdiction concerning or relating to bribery, kickbacks or corruption including.",
    "bbox": [
      179,
      469,
      1000,
      482
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "the United States Foreign Corrupt Practices Act of 1977, the Anti-Kickback Statute, the UK Bribery Act 2010, any Laws enacted pursuant to the",
    "bbox": [
      112,
      486,
      1000,
      498
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "OECD Convention on Combating Bribery of Foreign Public Officials, and other similar anti-corruption legislation in other jurisdictions, as may be",
    "bbox": [
      111,
      501,
      1000,
      514
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "amended from time to time and each to the extent applicable to a Party.",
    "bbox": [
      111,
      516,
      637,
      531
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "Source: SIGA TECHNOLOGIES INC, 8-K, 6/3/2019",
    "bbox": [
      133,
      1000,
      528,
      1000
    ],
    "label": 38,
    "category": "Insurance"
  }
]